Home › MICHELSON DIAGNOSTICS LTD › VivoSight
VivoSight
MICHELSON DIAGNOSTICS LTD · Model VivoSight Dx · UDI-DI 05060507260012
NQQ
Prescription
1
510(k) clearances
69
Adverse events
3
Recalls
27
Facilities
Description
The VivoSight Dx is indicated for use in the two-dimensional, cross-sectional, real-time imaging of external tissues of the human body. This indicated use allows imaging of tissue microstructure including skin, and enables detection and display of regions within the scanned area that are in motion (Dynamic OCT) to aid trained and competent clinicians in their assessment of a patient's clinical conditions.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2018-04-11 | Ninepoint Medical Inc. | Distal tips of the probes may detach from the probe shaft during use. |
| 2011-12-22 | Imalux Corporation | During an FDA inspection, the firm was notified that the wrong tubing was used during the manufacture of the probe for the unit. |
| 2010-07-20 | Optovue Inc. | Use of the CAM attachment may result in a positioning anomaly and mistreatment in the eyes of the patient. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
